MP
MFN Partners Portfolio holdings
AUM
$4.67B
This Quarter Return
-7.27%
1 Year Return
+18.61%
3 Year Return
+159.09%
5 Year Return
+255.66%
10 Year Return
–
AUM
$669M
AUM Growth
+$669M
(+6.2%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
16.29%
Top 10 Holdings %
Top 10 Hldgs %
98.01%
Holding
17
New
–
Increased
5
Reduced
3
Closed
3
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$84.1M |
| 2 |
Liberty Global Class C
LBTYK
|
$56.5M |
| 3 |
Cheniere Energy
LNG
|
$18.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$12.9M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$7.99M |
Top Sells
| 1 |
Goldman Sachs
GS
|
$35.6M |
| 2 |
XPO
XPO
|
$15.3M |
| 3 |
Takeda Pharmaceutical
TAK
|
$13.9M |
| 4 |
Navient
NAVI
|
$3.34M |
| 5 |
GTT
GTT Communications, Inc.
GTT
|
$2.53M |
Sector Composition
| 1 | Healthcare | 46.8% |
| 2 | Communication Services | 23.22% |
| 3 | Energy | 14.85% |
| 4 | Industrials | 7.49% |
| 5 | Utilities | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $236M | 35.22% |
1,400,101
+500,000
| +56% | +$84.1M |
|
2
Fox Class A
FOXA
$26.6B
| $74.7M | 11.17% |
2,369,331
| – | – |
|
|
3
Liberty Global Class C
LBTYK
$4.07B
| $71.4M | 10.67% |
3,000,000
+2,374,442
| +380% | +$56.5M |
|
|
4
Cheniere Energy
LNG
$53.1B
| $66.2M | 9.9% |
1,050,000
+300,000
| +40% | +$18.9M |
|
|
5
Ironwood Pharmaceuticals
IRWD
$214M
| $55.3M | 8.26% |
6,439,541
+1,500,000
| +30% | +$12.9M |
|
|
6
XPO
XPO
$15.3B
| $50.1M | 7.49% |
700,000
-213,935
| -23% | -$15.3M |
|
|
PXD
7
DELISTED
Pioneer Natural Resource Co.
PXD
| $33.1M | 4.95% |
263,500
+63,500
| +32% | +$7.99M |
|
8
PG&E
PCG
$33.6B
| $28M | 4.19% |
2,800,000
| – | – |
|
|
FG
9
DELISTED
FGL Holdings Ordinary Shares
FG
| $23.1M | 3.46% |
2,896,186
-103,814
| -3% | -$828K |
|
10
Cyclerion Therapeutics
CYCN
$7.91M
| $18M | 2.7% |
1,487,874
| – | – |
|
|
GTT
11
DELISTED
GTT Communications, Inc.
GTT
| $9.24M | 1.38% |
981,143
-268,857
| -22% | -$2.53M |
|
12
Evolus
EOLS
$494M
| $1.87M | 0.28% |
120,000
| – | – |
|
13
Aclaris Therapeutics
ACRS
$209M
| $1.62M | 0.24% |
1,500,000
| – | – |
|
|
RVNC
14
DELISTED
Revance Therapeutics, Inc.
RVNC
| $598K | 0.09% |
46,000
| – | – |
|
|
15
Goldman Sachs
GS
$226B
| – | – |
-173,811
| Closed | -$35.6M |
|
|
16
Navient
NAVI
$1.36B
| – | – |
-244,300
| Closed | -$3.34M |
|
|
17
Takeda Pharmaceutical
TAK
$47.3B
| – | – |
-785,000
| Closed | -$13.9M |
|